BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2830022)

  • 1. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator.
    Webster N; Jin JR; Green S; Hollis M; Chambon P
    Cell; 1988 Jan; 52(2):169-78. PubMed ID: 2830022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements.
    Tanaka M; Grossniklaus U; Herr W; Hernandez N
    Genes Dev; 1988 Dec; 2(12B):1764-78. PubMed ID: 2853685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The yeast GAL4 protein transactivates the polyomavirus origin of DNA replication in mouse cells.
    Baru M; Shlissel M; Manor H
    J Virol; 1991 Jul; 65(7):3496-503. PubMed ID: 1645781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mammalian viral enhancer confers transcriptional regulation in yeast.
    Fodor EJ; Yen TS; Rutter WJ
    J Biol Chem; 1988 Jul; 263(20):9569-72. PubMed ID: 2838470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4.
    Harshman KD; Moye-Rowley WS; Parker CS
    Cell; 1988 Apr; 53(2):321-30. PubMed ID: 2834068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Gal4-UAS technique for targeted gene expression in the zebrafish.
    Scheer N; Campos-Ortega JA
    Mech Dev; 1999 Feb; 80(2):153-8. PubMed ID: 10072782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild type GAL4 binds cooperatively to the GAL1-10 UASG in vitro.
    Kang T; Martins T; Sadowski I
    J Biol Chem; 1993 May; 268(13):9629-35. PubMed ID: 8486650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative effect of the transcriptional activator GAL4.
    Gill G; Ptashne M
    Nature; 1988 Aug; 334(6184):721-4. PubMed ID: 3412449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A yeast activity can substitute for the HeLa cell TATA box factor.
    Cavallini B; Huet J; Plassat JL; Sentenac A; Egly JM; Chambon P
    Nature; 1988 Jul; 334(6177):77-80. PubMed ID: 3290688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins.
    Braselmann S; Graninger P; Busslinger M
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1657-61. PubMed ID: 8446579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors.
    Berger SL; Cress WD; Cress A; Triezenberg SJ; Guarente L
    Cell; 1990 Jun; 61(7):1199-208. PubMed ID: 2163758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.
    Peshavaria M; Cissell MA; Henderson E; Petersen HV; Stein R
    Mol Endocrinol; 2000 Dec; 14(12):1907-17. PubMed ID: 11117522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAL4 disrupts a repressing nucleosome during activation of GAL1 transcription in vivo.
    Axelrod JD; Reagan MS; Majors J
    Genes Dev; 1993 May; 7(5):857-69. PubMed ID: 8491382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAL4 derivatives function alone and synergistically with mammalian activators in vitro.
    Lin YS; Carey MF; Ptashne M; Green MR
    Cell; 1988 Aug; 54(5):659-64. PubMed ID: 3044607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAL4 activates gene expression in mammalian cells.
    Kakidani H; Ptashne M
    Cell; 1988 Jan; 52(2):161-7. PubMed ID: 2830021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter.
    Bondesson M; Mannervik M; Akusjärvi G; Svensson C
    Nucleic Acids Res; 1994 Aug; 22(15):3053-60. PubMed ID: 8065919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo "photofootprint" changes at sequences between the yeast GAL1 upstream activating sequence and "TATA" element require activated GAL4 protein but not a functional TATA element.
    Selleck SB; Majors J
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5399-403. PubMed ID: 3041409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between a half-site and an imperfect estrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene.
    Petit FG; Métivier R; Valotaire Y; Pakdel F
    Eur J Biochem; 1999 Jan; 259(1-2):385-95. PubMed ID: 9914518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.